84
60
Growth Score
-4 pts
Heat Score
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
2255121
Sinosi develops a transepicardial chemical ablation device for the treatment of atrial fibrillation.
About the Company
Sinosi develops a transepicardial chemical ablation device for the treatment of atrial fibrillation. It is an innovative technology company focusing on the research and development of new technologies and products in the field of cardiac electrophysiology.
Established in March 2017, Sinosi is exclusively invested by Danlu Capital and is located
in the national biomedical industry base in Pingshan District, Shenzhen.
